Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox

被引:220
作者
Tsikas, D [1 ]
Böger, RH [1 ]
Sandmann, J [1 ]
Bode-Böger, SM [1 ]
Frölich, JC [1 ]
机构
[1] Hannover Med Sch, Inst Clin Pharmacol, D-30623 Hannover, Germany
来源
FEBS LETTERS | 2000年 / 478卷 / 1-2期
关键词
L-arginine paradox; nitric oxide synthase; endogenous inhibitor; methylarginine; asymmetric dimethylarginine;
D O I
10.1016/S0014-5793(00)01686-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
L-Arginine, the substrate of nitric oxide (NO) synthases (SOSs), is found in the mammalian organism at concentrations by far exceeding K-M values of these enzymes. Therefore, additional L-arginine should not enhance NO formation. In vivo, however, increasing L-arginine concentration in plasma has been shown repeatedly to increase NO production. This phenomenon has been named the L-arginine parades; it has found no satisfactory explanation so far, In the present work, evidence for the hypothesis that the endogenous NOS inhibitors methylarginines, asymmetric dimethylarginine being the most powerful (IC50 1.5 mu M), are responsible for the L-arginine parades is presented. (C) 2000 Federation of European Biochemical Societies, Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 40 条
[1]  
Bode-Böger SM, 1999, J INVEST MED, V47, P43
[2]   L-arginine-induced vasodilation in healthy humans:: Pharmacokinetic-pharmacodynamic relationship [J].
Bode-Böger, SM ;
Böger, RH ;
Galland, A ;
Tsikas, D ;
Frölich, JC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (05) :489-497
[3]   L-ARGININE INFUSION DECREASES PERIPHERAL ARTERIAL RESISTANCE AND INHIBITS PLATELET-AGGREGATION IN HEALTHY-SUBJECTS [J].
BODEBOGER, SM ;
BOGER, RH ;
CREUTZIG, A ;
TSIKAS, D ;
GUTZKI, FM ;
ALEXANDER, K ;
FROLICH, JC .
CLINICAL SCIENCE, 1994, 87 (03) :303-310
[4]   Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits [J].
BodeBoger, SM ;
Boger, RH ;
Kienke, S ;
Junker, W ;
Frolich, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) :598-603
[5]   L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia - A randomized, controlled study [J].
BodeBoger, SM ;
Boger, RH ;
Alfke, H ;
Heinzel, D ;
Tsikas, D ;
Creutzig, A ;
Alexander, K ;
Frolich, JC .
CIRCULATION, 1996, 93 (01) :85-90
[6]   Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Szuba, A ;
Tsao, PS ;
Chan, JR ;
Tangphao, O ;
Blaschke, TF ;
Cooke, JP .
CIRCULATION, 1998, 98 (18) :1842-1847
[7]   LONG-TERM ADMINISTRATION OF L-ARGININE, L-NAME, AND THE EXOGENOUS NO DONOR MOLSIDOMINE MODULATES URINARY NITRATE AND CGMP EXCRETION IN RATS [J].
BOGER, RH ;
BODEBOGER, SM ;
GERECKE, U ;
FROLICH, JC .
CARDIOVASCULAR RESEARCH, 1994, 28 (04) :494-499
[8]   Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease [J].
Boger, RH ;
BodeBoger, SM ;
Thiele, W ;
Junker, W ;
Alexander, K ;
Frolich, JC .
CIRCULATION, 1997, 95 (08) :2068-2074
[9]  
BOGER RH, 1995, ATHEROSCLEROSIS, V117, P273, DOI 10.1016/0021-9150(95)05582-H
[10]   The L-arginine-nitric oxide pathway: Role in atherosclerosis and therapeutic implications [J].
Boger, RH ;
BodeBoger, SM ;
Frolich, JC .
ATHEROSCLEROSIS, 1996, 127 (01) :1-11